Abstract Objective To update the 2000 American Academy of Neurology (AAN) practice
parameter on anticonvulsant prophylaxis in patients with newly diagnosed brain tumors …

Seizures are among the most common clinical signs in people with glioblastoma. Advances
over the past 5 years, including new clinical trial data, have increased the understanding of …

Interest in the use of pharmacological ascorbate as a treatment for cancer has increased
considerably since it was introduced by Cameron and Pauling in the 1970s. Recently …

OBJECTIVE De novo seizure following craniotomy (DSC) for nontraumatic pathology may
adversely affect medical and neurological outcomes in patients with no history of seizures …

OBJECTIVE Seizures are common and significantly disabling for patients with brain
metastases (BMs). Although resection can provide seizure control, a subset of patients with …

This review is intended to provide a summary of the literature pertaining to the perioperative
care of neurosurgical patients and patients with neurological diseases. General topics …

Purpose This study aim to identify the clinical risk factors of and to develop a radiomics-
based predictive model for early postoperative seizure. Methods We retrospectively …

Prophylactic antiepileptic drug (pAED) use for craniotomy surgery is currently not supported
in literature [1],[2],[3],[4],[5] except possibly in traumatic brain injury (TBI)[6]. Post craniotomy …

Introduction: Resection of intra-axial tumors (IaT) in eloquent brain regions risks major
postoperative neurological deficits. Awake craniotomy is often used to navigate these areas; …

Background Brain tumor patients tend to develop postoperative epileptic seizures, which
can lead to an unfavorable outcome. Although the incidence of postoperative epileptic …